Effects of Lactobacillus plantarum and Leuconostoc mesenteroides Probiotics on Human Seasonal and Avian Influenza Viruses |
Bae, Joon-Yong
(Department of Microbiology, Institute for Viral Diseases, College of Medicine, Korea University)
Kim, Jin Il (Department of Microbiology, Institute for Viral Diseases, College of Medicine, Korea University) Park, Sehee (Department of Microbiology, Institute for Viral Diseases, College of Medicine, Korea University) Yoo, Kirim (Department of Microbiology, Institute for Viral Diseases, College of Medicine, Korea University) Kim, In-Ho (Korea Food Research Institute) Joo, Wooha (Daesang Co., Ltd.) Ryu, Byung Hee (Daesang Co., Ltd.) Park, Mee Sook (Department of Microbiology, Institute for Viral Diseases, College of Medicine, Korea University) Lee, Ilseob (Department of Microbiology, Institute for Viral Diseases, College of Medicine, Korea University) Park, Man-Seong (Department of Microbiology, Institute for Viral Diseases, College of Medicine, Korea University) |
1 | Demicheli V, Jefferson T, Di Pietrantonj C, Ferroni E, Thorning S, Thomas RE, et al. 2018. Vaccines for preventing influenza in the elderly. Cochrane Database Syst. Rev. 2: CD004876. |
2 | Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, Pulendran B, Garcia-Sastre A. 2010. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc. Natl. Acad. Sci. USA 107: 11531-11536. DOI |
3 | Kim JI, Park S, Lee I, Lee S, Shin S, Won Y, et al. 2012. GFPexpressing influenza A virus for evaluation of the efficacy of antiviral agents. J. Microbiol. 50: 359-362. DOI |
4 | Lee I, Kim JI, Park S, Bae JY, Yoo K, Yun SH, et al. 2017. Single PA mutation as a high yield determinant of avian influenza vaccines. Sci. Rep. 7: 40675. DOI |
5 | Park S, Kim JI, Lee I, Lee S, Hwang MW, Bae JY, et al. 2013. Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses. Biochem. Biophys. Res. Commun. 440: 14-19. DOI |
6 | Centers for Disease Control and Prevention (CDC). 2018. Disease burden of influenza. Available at https://www.cdc.gov/flu/about/disease/burden.htm.Accessed March 16, 2018. |
7 | World Health Organization (WHO). 2018. Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO. Available at http://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/. Accessed March 2, 2018. |
8 | Food and Agriculture Organization of the United Nations (FAO). 2018. H7N9 situation. Available at http://www.fao.org/ag/againfo/programmes/en/empres/H7N9/situation_ update.html). Accessed March 28, 2018. |
9 | Starosila D, Rybalko S, Varbanetz L, Ivanskaya N, Sorokulova I. 2017. Anti-influenza activity of a Bacillus subtilis probiotic strain. Antimicrob. Agents Chemother. 61: e00539-17. |
10 | Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM, et al. 2011. Antiviral agents for the treatment and chemoprophylaxis of influenza - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 60: 1-24. |
11 | Centers for Disease Control and Prevention (CDC). 2018. Seasonal influenza vaccine effectiveness, 2005-2018. Available at https://www.cdc.gov/flu/professionals/vaccination/ effectiveness-studies.htm). Accessed March 15, 2018. |
12 | Kwak MK, Liu R, Kwon JO, Kim MK, Kim AH, Kang SO. 2013. Cyclic dipeptides from lactic acid bacteria inhibit proliferation of the influenza A virus. J. Microbiol. 51: 836-843. DOI |
13 | Maeda N, Nakamura R, Hirose Y, Murosaki S, Yamamoto Y, Kase T, et al. 2009. Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice. Int. Immunopharmacol. 9: 1122-1125. DOI |
14 | Kiso M, Takano R, Sakabe S, Katsura H, Shinya K, Uraki R, et al. 2013. Protective efficacy of orally administered, heatkilled Lactobacillus pentosus b240 against influenza A virus. Sci. Rep. 3: 1563. DOI |
15 | Goto H, Sagitani A, Ashida N, Kato S, Hirota T, Shinoda T, et al. 2013. Anti-influenza virus effects of both live and nonlive Lactobacillus acidophilus L-92 accompanied by the activation of innate immunity. Br. J. Nutr. 110: 1810-1818. DOI |
16 | Kim JI, Lee I, Park S, Park MS. 2012. Surface glycoproteins determine the feature of the 2009 pandemic H1N1 virus. BMB Rep. 45: 653-658. DOI |
17 | Lee YD, Hong YF, Jeon B, Jung BJ, Chung DK, Kim H. 2016. Differential cytokine regulatory effect of three Lactobacillus strains isolated from fermented foods. J. Microbiol. Biotechnol. 26: 1517-1526. DOI |
18 | Kim JI, Lee I, Park S, Hwang MW, Bae JY, Lee S, et al. 2013. Genetic requirement for hemagglutinin glycosylation and its implications for influenza A H1N1 virus evolution. J. Virol. 87: 7539-7549. DOI |
19 | Park S, Kim JI, Lee I, Bae JY, Yoo K, Nam M, et al. 2017. Adaptive mutations of neuraminidase stalk truncation and deglycosylation confer enhanced pathogenicity of influenza A viruses. Sci. Rep. 7: 10928. DOI |
20 | Park S, Kim JI, Bae JY, Yoo K, Kim H, Kim IH, et al. 2018. Effects of heat-killed Lactobacillus plantarum against influenza viruses in mice. J. Microbiol. 56: 145-149. DOI |
21 | Guillemard E, Tondu F, Lacoin F, Schrezenmeir J. 2010. Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. Br. J. Nutr. 103: 58-68. DOI |
22 | Boge T, Remigy M, Vaudaine S, Tanguy J, Bourdet-Sicard R, van der Werf S. 2009. A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 27: 5677-5684. DOI |
23 | Palese P. 2004. Influenza: old and new threats. Nat. Med. 10: S82-S87. DOI |
24 | Neumann G, Kawaoka Y. 2011. The first influenza pandemic of the new millennium. Influenza Other Respir. Viruses 5: 157-166. DOI |
25 | Jung JY, Lee SH, Jeon CO. 2014. Kimchi microflora: history, current status, and perspectives for industrial kimchi production. Appl. Microbiol. Biotechnol. 98: 2385-2393. DOI |
26 | Bitterman R, Eliakim-Raz N, Vinograd I, Zalmanovici Trestioreanu A, Leibovici L, Paul M. 2018. Influenza vaccines in immunosuppressed adults with cancer. Cochrane Database Syst. Rev. 2: CD008983. |
27 | Yeh TL, Shih PC, Liu SJ, Lin CH, Liu JM, Lei WT, et al. 2018. The influence of prebiotic or probiotic supplementation on antibody titers after influenza vaccination: a systematic review and meta-analysis of randomized controlled trials. Drug Des Devel. Ther. 12: 217-230. DOI |
28 | Van Puyenbroeck K, Hens N, Coenen S, Michiels B, Beunckens C, Molenberghs G, et al. 2012. Efficacy of daily intake of Lactobacillus casei Shirota on respiratory symptoms and influenza vaccination immune response: a randomized, double-blind, placebo-controlled trial in healthy elderly nursing home residents. Am. J. Clin. Nutr. 95: 1165-1171. DOI |
29 | Pessione E, Cirrincione S. 2016. Bioactive molecules released in food by lactic acid bacteria: encrypted peptides and biogenic amines. Front. Microbiol. 7: 876. |
30 | Cho J, Lee D, Yang C, Jeon J, Kim J, Han H. 2006. Microbial population dynamics of kimchi, a fermented cabbage product. FEMS Microbiol. Lett. 257: 262-267. DOI |
31 | Choi CY, Kim YH, Oh S, Lee HJ, Kim JH, Park SH, et al. 2017. Anti-inflammatory potential of a heat-killed Lactobacillus strain isolated from kimchi on house dust mite-induced atopic dermatitis in NC/Nga mice. J. Appl. Microbiol. 123: 535-543. DOI |
32 | Webster RG, Govorkova EA. 2014. Continuing challenges in influenza. Ann. N. Y. Acad. Sci. 1323: 115-139. DOI |
33 | Lam TT, Wang J, Shen Y, Zhou B, Duan L, Cheung CL, et al. 2013. The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature 502: 241-244. DOI |
34 | MacDonald TT, Bell I. 2010. Probiotics and the immune response to vaccines. Proc. Nutr. Soc. 69: 442-446. DOI |
35 | Wright PF, Neumann G, Kawaoka Y. 2013. Orthomyxoviruses. In Knipe DM, Howley PM (eds.), Fields Virology, 6th Ed. Ch. 41. Lippincott Williams & Wilkins, Philadelphia, USA. |
36 | Krammer F, Garcia-Sastre A, Palese P. 2017. Is it possible to develop a "universal" influenza virus vaccine? Toward a universal influenza virus vaccine: potential target antigens and critical aspects for vaccine development. Cold Spring Harb. Perspect. Biol. 2017: a028845. |
37 | Hill D, Sugrue I, Arendt E, Hill C, Stanton C, Ross RP. 2017. Recent advances in microbial fermentation for dairy and health. F1000Res. 6: 751. DOI |
38 | Palese P, Tobita K, Ueda M, Compans RW. 1974. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61: 397-410. DOI |
39 | Jung YJ, Lee YT, Ngo VL, Cho YH, Ko EJ, Hong SM, et al. 2017. Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infection. Sci. Rep. 7: 17360. DOI |
40 | Lei WT, Shih PC, Liu SJ, Lin CY, Yeh TL. 2017. Effect of probiotics and prebiotics on immune response to influenza vaccination in adults: a systematic review and meta-analysis of randomized controlled trials. Nutrients 9: 1175. DOI |
41 | Park S, Kim JI, Park MS. 2012. Antiviral agents against influenza viruses. J. Bacteriol. Virol. 42: 284-293. DOI |
42 | Nachbagauer R, Krammer F. 2017. Universal influenza virus vaccines and therapeutic antibodies. Clin. Microbiol. Infect. 23: 222-228. DOI |
43 | Harding AT, Heaton NS. 2018. Efforts to improve the seasonal influenza vaccine. Vaccines (Basel) 6: E19. DOI |
44 | Naesens L, Stevaert A, Vanderlinden E. 2016. Antiviral therapies on the horizon for influenza. Curr. Opin. Pharmacol. 30: 106-115. DOI |
45 | Zimmermann P, Curtis N. 2018. The influence of probiotics on vaccine responses - a systematic review. Vaccine 36: 207-213. DOI |
46 | Vitetta L, Saltzman ET, Thomsen M, Nikov T, Hall S. 2017. Adjuvant probiotics and the intestinal microbiome: enhancing vaccines and immunotherapy outcomes. Vaccines (Basel) 5: 50. DOI |
47 | Chen MF, Weng KF, Huang SY, Liu YC, Tseng SN, Ojcius DM, et al. 2017. Pretreatment with a heat-killed probiotic modulates monocyte chemoattractant protein-1 and reduces the pathogenicity of influenza and enterovirus 71 infections. Mucosal Immunol. 10: 215-227. DOI |
48 | de Vrese M, Winkler P, Rautenberg P, Harder T, Noah C, Laue C, et al. 2006. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine 24: 6670-6674. DOI |